At the Sep 2013 meeting of the
European Medicines Agency’s
Committee for Medicinal Products
for Human Use (CHMP), eleven new
products were recommended for
approval.
Kadcycla and Xofigo in oncology,
Abilify Maintena, Memantine
Accord and Levadopa CES in
neurology/psychiatry, Vitekta
and Fluenz Tetra in immunology,
Invokana for diabetes, NovoEight
and Relvar Ellipta in respiratory
medicine, and Lidocaine /
Prilocaine Plethora for premature
ejaculation were cited.
For more details CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Sep 13
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.